View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
December 9, 2009

Screening Reduces Prostate Cancer Deaths, Report Says

Prostate-specific antigen screening for prostate cancer has reduced cancer deaths up to 31%, according to a new report. The European Randomized Study of Screening for Prostate Cancer (ERSPC) Report said personal risk assessment will reduce the number of unnecessary biopsies by 33%.

By cms admin

Prostate-specific antigen screening for prostate cancer has reduced cancer deaths up to 31%, according to a new report.

The European Randomized Study of Screening for Prostate Cancer (ERSPC) Report said personal risk assessment will reduce the number of unnecessary biopsies by 33%.

The ERSPC study ran from 1992 and involved 162,000 men between the ages of 55 and 69, in seven European countries.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Get important industry news and analysis sent to your inbox
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Hospital Management